Antitrust Antitrust

Roche's Covid-19 testing formula draws Dutch antitrust scrutiny

By Michael Acton
  • 27 Mar 2020 12:38
  • 27 Mar 2020 13:02

Swiss healthcare multinational Roche has drawn scrutiny from the Dutch Competition Authority over a formula used for its Covid-19 tests, MLex has learned.

The company has now shared it with the Dutch government in the wake of reports that laboratories were unable to make their own versions of a solution used in

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Michael Acton

Senior Correspondent

Michael is a senior correspondent for MLex in San Francisco, where he moved in 2020 after working in our Brussels bureau. Before joining MLex, he reported on EU politics as the Financial Times’ Nico Colchester Fellow in Brussels. Michael has a degree in International Relations and Politics from the University of Cambridge, and a degree in History and French from University College London and Paris IV Sorbonne.

Discover MLex

Stay on top of global regulatory developments


Latest News